Literature DB >> 26100623

Molecular Determinants for the Inactivation of the Retinoblastoma Tumor Suppressor by the Viral Cyclin-dependent Kinase UL97.

Satoko Iwahori1, Morgan Hakki2, Sunwen Chou3, Robert F Kalejta4.   

Abstract

The retinoblastoma (Rb) tumor suppressor restricts cell cycle progression by repressing E2F-responsive transcription. Cellular cyclin-dependent kinase (CDK)-mediated Rb inactivation through phosphorylation disrupts Rb-E2F complexes, stimulating transcription. The human cytomegalovirus (HCMV) UL97 protein is a viral CDK (v-CDK) that phosphorylates Rb. Here we show that UL97 phosphorylates 11 of the 16 consensus CDK sites in Rb. A cleft within Rb accommodates peptides with the amino acid sequence LXCXE. UL97 contains three such motifs. We determined that the first LXCXE motif (L1) of UL97 and the Rb cleft enhance UL97-mediated Rb phosphorylation. A UL97 mutant with a non-functional L1 motif (UL97-L1m) displayed significantly reduced Rb phosphorylation at multiple sites. Curiously, however, it efficiently disrupted Rb-E2F complexes but failed to relieve Rb-mediated repression of E2F reporter constructs. The HCMV immediate early 1 protein cooperated with UL97-L1m to inactivate Rb in transfection assays, likely indicating that cells infected with a UL97-L1m mutant virus show no defects in growth or E2F-responsive gene expression because of redundant viral mechanisms to inactivate Rb. Our data suggest that UL97 possesses a mechanism to elicit E2F-dependent gene expression distinct from disruption of Rb-E2F complexes and dependent upon both the L1 motif of UL97 and the cleft region of Rb.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  cancer; cyclin-dependent kinase (CDK); cytomegalovirus; herpesvirus; oncogene; phosphorylation; retinoblastoma protein (pRb, RB); transcription

Mesh:

Substances:

Year:  2015        PMID: 26100623      PMCID: PMC4528131          DOI: 10.1074/jbc.M115.660043

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  92 in total

Review 1.  Interactions of SV40 large T antigen and other viral proteins with retinoblastoma tumour suppressor.

Authors:  Changwook Lee; Yunje Cho
Journal:  Rev Med Virol       Date:  2002 Mar-Apr       Impact factor: 6.989

2.  Phosphorylation puts the pRb tumor suppressor into shape.

Authors:  Andreas M F Heilmann; Nicholas J Dyson
Journal:  Genes Dev       Date:  2012-06-01       Impact factor: 11.361

3.  Diverse cytomegalovirus UL27 mutations adapt to loss of viral UL97 kinase activity under maribavir.

Authors:  Sunwen Chou
Journal:  Antimicrob Agents Chemother       Date:  2008-11-03       Impact factor: 5.191

4.  The human cytomegalovirus IE1-72 protein interacts with the cellular p107 protein and relieves p107-mediated transcriptional repression of an E2F-responsive promoter.

Authors:  E E Poma; T F Kowalik; L Zhu; J H Sinclair; E S Huang
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

5.  Human cytomegalovirus pp71 stimulates cell cycle progression by inducing the proteasome-dependent degradation of the retinoblastoma family of tumor suppressors.

Authors:  Robert F Kalejta; Jill T Bechtel; Thomas Shenk
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

6.  Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A.

Authors:  B A Schulman; D L Lindstrom; E Harlow
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

7.  Differential initiation of innate immune responses induced by human cytomegalovirus entry into fibroblast cells.

Authors:  Laura K Juckem; Karl W Boehme; Adam L Feire; Teresa Compton
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

8.  Tale of a tegument transactivator: the past, present and future of human CMV pp71.

Authors:  Rhiannon R Penkert; Robert F Kalejta
Journal:  Future Virol       Date:  2012-09-01       Impact factor: 1.831

9.  Phosphorylation of a specific cdk site in E2F-1 affects its electrophoretic mobility and promotes pRB-binding in vitro.

Authors:  D S Peeper; P Keblusek; K Helin; M Toebes; A J van der Eb; A Zantema
Journal:  Oncogene       Date:  1995-01-05       Impact factor: 9.867

10.  Phosphorylation of E2F-1 by cyclin A-cdk2.

Authors:  M Kitagawa; H Higashi; I Suzuki-Takahashi; K Segawa; S K Hanks; Y Taya; S Nishimura; A Okuyama
Journal:  Oncogene       Date:  1995-01-19       Impact factor: 9.867

View more
  14 in total

1.  Phosphorylation of transcriptional regulators in the retinoblastoma protein pathway by UL97, the viral cyclin-dependent kinase encoded by human cytomegalovirus.

Authors:  Satoko Iwahori; Robert F Kalejta
Journal:  Virology       Date:  2017-12       Impact factor: 3.616

2.  Human cytomegalovirus-encoded viral cyclin-dependent kinase (v-CDK) UL97 phosphorylates and inactivates the retinoblastoma protein-related p107 and p130 proteins.

Authors:  Satoko Iwahori; Angie C Umaña; Halena R VanDeusen; Robert F Kalejta
Journal:  J Biol Chem       Date:  2017-03-13       Impact factor: 5.157

3.  Deficiencies in Cellular Processes Modulated by the Retinoblastoma Protein Do Not Account for Reduced Human Cytomegalovirus Replication in Its Absence.

Authors:  Halena R VanDeusen; Robert F Kalejta
Journal:  J Virol       Date:  2015-09-16       Impact factor: 5.103

4.  Cyclins B1, T1, and H differ in their molecular mode of interaction with cytomegalovirus protein kinase pUL97.

Authors:  Mirjam Steingruber; Lena Keller; Eileen Socher; Sabrina Ferre; Anne-Marie Hesse; Yohann Couté; Friedrich Hahn; Nicole Büscher; Bodo Plachter; Heinrich Sticht; Manfred Marschall
Journal:  J Biol Chem       Date:  2019-02-19       Impact factor: 5.157

Review 5.  Virus-host protein interactions as footprints of human cytomegalovirus replication.

Authors:  Matthew D Tyl; Cora N Betsinger; Ileana M Cristea
Journal:  Curr Opin Virol       Date:  2021-12-16       Impact factor: 7.090

6.  Direct Substrate Identification with an Analog Sensitive (AS) Viral Cyclin-Dependent Kinase (v-Cdk).

Authors:  Angie C Umaña; Satoko Iwahori; Robert F Kalejta
Journal:  ACS Chem Biol       Date:  2017-12-19       Impact factor: 5.100

Review 7.  Overview of Human Cytomegalovirus Pathogenesis.

Authors:  Heather L Fulkerson; Maciej T Nogalski; Donna Collins-McMillen; Andrew D Yurochko
Journal:  Methods Mol Biol       Date:  2021

8.  Activation of E2F-dependent transcription by the mouse cytomegalovirus M117 protein affects the viral host range.

Authors:  Eléonore Ostermann; Stefan Loroch; Zhikang Qian; Albert Sickmann; Lüder Wiebusch; Wolfram Brune
Journal:  PLoS Pathog       Date:  2018-12-10       Impact factor: 6.823

9.  Proteomic Interaction Patterns between Human Cyclins, the Cyclin-Dependent Kinase Ortholog pUL97 and Additional Cytomegalovirus Proteins.

Authors:  Mirjam Steingruber; Alexandra Kraut; Eileen Socher; Heinrich Sticht; Anna Reichel; Thomas Stamminger; Bushra Amin; Yohann Couté; Corina Hutterer; Manfred Marschall
Journal:  Viruses       Date:  2016-08-18       Impact factor: 5.048

10.  Interpretation of EBV infection in pan-cancer genome considering viral life cycle: LiEB (Life cycle of Epstein-Barr virus).

Authors:  Hyojin Song; Yoojoo Lim; Hogune Im; Jeong Mo Bae; Gyeong Hoon Kang; Junhak Ahn; Daehyun Baek; Tae-You Kim; Sung-Soo Yoon; Youngil Koh
Journal:  Sci Rep       Date:  2019-03-05       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.